Global Food Allergy Treatment Market to Reach $12.14 Billion by 2029, Growing at 12.2% CAGR

What Is the Expected Size and Growth Rate of the Food Allergy Treatment Market?
In the past few years, the size of the food allergy treatment market has seen a swift expansion. It is projected to enlarge from a worth of $6.82 billion in 2024 to approximately $7.67 billion in 2025, maintaining a compound annual growth rate (CAGR) of 12.5%. Several factors have contributed to this growth during the past period, including a surge in the number of food allergy cases, an increase in regulatory approvals, advancements in emergency treatments, and substantial investments in state-of-the-art technologies.

Anticipations are high for the food allergy treatment market to undergo swift expansion in the upcoming years, with a projection of reaching $12.14 billion by 2029, compounded annually at 12.2%. The growth spur projected during the forecast period can be ascribed to several factors such as an expanding elderly population, an escalating rate of food allergy diagnoses, increasing healthcare expenditure, a surge in asthma cases, and a growth in occurrences of food allergies. The forecast period also expects to witness significant trends like noteworthy innovation and advancements in technology, enhancements in medical and diagnostic technology, augmented usage of mobile applications and telemedicine amenities, an upswing in the quantum of research and development activities, along with a surge in drug approvals and introductions.

What Key Elements Are Boosting Growth in the Food Allergy Treatment Market?
A surge in the incidence of food adulteration is likely to push the food allergy treatment market's growth forward. To put it another way, food adulteration is the deliberate modification of food products either by the addition of poor-quality, harmful, unapproved substances, or by removing excellent components, often sacrificing the quality and safety of the food for increased volume or improved visual appeal. Various reasons are responsible for the rise in food adulteration, including economical benefits, intricate supply chains, insufficiency of regulation, technological progress, demand for convenient food options, globalization, environmental factors, awareness amongst consumers, profit margins and feeble administration of regulations. The main driving factors for growing food adulteration are the increasing demand for cheaper alternatives which typically encourages manufacturers to resort to unethical practices in order to reduce cost and increase profits. The likelihood of allergic reactions increases with food adulteration due to the inclusion of allergens or by diminishing the safety and trustworthiness of the food supply. To illustrate, Europol, a government agency based in the Netherlands, revealed in November 2022 that nearly 27,000 tons of fake food and 15 million liters of alcoholic drinks were seized by authorities across 26 countries as part of Operation OPSON XI which Europol coordinated, spanning from December 2021 to May 2022. Thus, the food allergy treatment market's growth is being spurred by the rise in food adulteration.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16684&type=smp

Which Leading Companies Are Shaping the Growth of the Food Allergy Treatment Market?
Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., Parexel International (MA) Corporation, Nestle Health Science, ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation

What Are the Major Trends Shaping the Food Allergy Treatment Market?
Leading companies in the food allergy treatment industry are pioneering new therapies such as monoclonal antibodies, aiming to target the fundamental causes of food allergies to offer more efficient treatments. Monoclonal antibodies are an encouraging new method in food allergy treatment, focusing particularly on parts of the immune system implicated in allergic responses to offer targeted, effective treatments. For example, in February 2024, Switzerland-based pharmaceutical giant Novartis AG obtained FDA authorization for Xolair (omalizumab), intended to lower IgE-mediated food allergies. As a humanized monoclonal antibody given through subcutaneous injection, Xolair operates by stunting the binding of IgE antibodies and reducing the release of chemicals that cause allergy symptoms. The FDA's approval hinged on positive results from the Phase III OUtMATCH study. The study demonstrated that a noticeably higher ratio of food allergy patients as young as one year old who were treated with Xolair were able to withstand small amounts of peanuts, milk, eggs, and cashews with no allergic reactions when compared to a placebo.

What Are the Key Segments of the Food Allergy Treatment Market?
The food allergy treatment market covered in this report is segmented -

1) By Drug Type: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anti-Cholinergic, Immuno-Modulators, Epinephrine, Immunotherapy
2) By Route Of Administration: Parenteral, Oral
3) By Allergen Type: Dairy Products, Poultry Product, Tree Nuts, Peanuts, Shellfish, Wheat, Soys, Other Allergens
4) By End-Use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses

Subsegments:
1) By Antihistamines: Oral Antihistamines, Topical Antihistamines, Intranasal Antihistamines
2) By Decongestants: Oral Decongestants, Nasal Decongestants
3) By Corticosteroids: Oral Corticosteroids, Topical Corticosteroids, Intranasal Corticosteroids
4) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil
5) By Leukotriene Inhibitors: Montelukast, Zafirlukast
6) By Nasal Anti-Cholinergic: Ipratropiu*m Bromide
7) By Immuno-Modulators: Omalizumab, Dupilumab
8) By Epinephrine: Injectable Epinephrine, Auto-Injectors
9) By Immunotherapy: Oral Immunotherapy (OIT), Sublingual Immunotherapy (SLIT), Epicutaneous Immunotherapy (EPIT)

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/food-allergy-treatment-global-market-report

Which Region Dominates the Food Allergy Treatment Market?
North America was the largest region in the food allergy treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Food Allergy Treatment Global Market Report?

- Market Size Analysis: Analyze the Food Allergy Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Food Allergy Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Food Allergy Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Food Allergy Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16684

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.